Back

Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Atrial fibrillation - Ablation Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Tomoka Yonishi

Osaka University Graduate School of Medicine, Osaka (Japan)

19 More presentations in this session

Presentation thumbnail
Doctor V. Orshanskaya (Saint Petersburg, RU)
Presentation thumbnail
Doctor I. Morishima (Ogaki, JP)
Abstract
Presentation thumbnail
Doctor K. Nakajima (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Doctor D. Hiraya (Tsukuba, JP)
Abstract
Presentation thumbnail
Doctor A. Bjorkenheim (Orebro, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Atrial fibrillation - Ablation

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources